Mycofoli 1000 Tablet contains Mycophenolate Sodium 1000 mg, a high-potency immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This tablet works by inhibiting inosine monophosphate dehydrogenase (IMPDH), suppressing T- and B-lymphocyte proliferation and reducing immune-mediated damage to transplanted organs. It is ideal for patients requiring maximum-dose immunosuppression in renal, cardiac, or hepatic transplant regimens, under strict medical supervision.
Clinically, Mycofoli 1000 Tablet is used in combination with calcineurin inhibitors and corticosteroids to maintain graft survival, minimize rejection episodes, and ensure post-transplant stability.
The tablet ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty pharmacies, and healthcare providers managing intensive post-transplant immunosuppressive therapy.
Common side effects may include nausea, diarrhea, vomiting, abdominal discomfort, headache, and mild infections. Rare but serious adverse effects include leukopenia, anemia, thrombocytopenia, severe infections, and allergic reactions.
Mycofoli 1000 Tablet is indicated for the prevention of organ transplant rejection in renal, cardiac, or hepatic transplant recipients. It is also used in the management of certain autoimmune disorders, as prescribed by a specialist.
Use Mycofoli 1000 Tablet strictly under medical supervision. Regular monitoring of blood counts, kidney and liver function, and infection status is essential. Inform your doctor if you have a history of bone marrow suppression, ongoing infections, or are taking other medications. Avoid live vaccines during therapy and seek immediate medical attention if severe infections, unusual bleeding, or persistent fever occur.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.